Switch Language
Alt tag
Bayer Logo Bayer Logo Bayer Logo

Bienvenido a Thrombosis Adviser

Información sobre trombosis venosa y arterial destinada

Artículos seleccionados

Study teaser image
When is the right time to start thinking about renal function in patients with AF?
2020_1_22_TA_VTE_Extended_treatment_tailoring
Extended Treatment for VTE: Tailoring Treatment for Patients Who Need it
2020_2_04_TA_ESC_2020_congress
Thrombosis Adviser at the European Society of Cardiology Congress 2020
2020_1_21_TA_SPAF_Patients_with_diabetes
Patients with diabetes and atrial fibrillation: How can the risk of cardiovascular death be reduced?

Escuche la serie de podcasts Thrombosis Adviser en inglés

Join more than 1.500 of your peers to stay up to date with the latest in thrombosis.

Sign up now!

Aspirina, EINSTEIN
CHOICE y tratamiento
de TEV a largo plazo

YYMMDD Author/Uploaded by

El profesor Paolo Prandoni analiza el papel del AAS en el tratamiento prolongado del TEV y analiza el reciente estudio EINSTEIN CHOICE, que comparó dos dosis de rivaroxabán con AAS para el tratamiento prolongado del TEV

N.º de autorización PP-XAR-ALL-1747-1

Artículos seleccionados

Study teaser image
ThrombosisAdviser at the European Society of Cardiology Congress 2019: Focus on Atrial Fibrillation
Study teaser image
Paediatric patients with VTE: Protecting the most challenging population
Study teaser image
Thrombosis Adviser at the European Society of Cardiology Congress 2019
Study teaser image
Making connections: Stroke risk in patients with multiple co-morbidities

Latest in Thrombosis

ThrombosisAdviser at
the European Society of
Cardiology Congress 2019

The European Society of Cardiology (ESC) congress is the largest cardio-vascular congress in the world. This year’s event also included the World Congress of Cardiology and attracted over 30,000 delegates, who gathered at the Paris Expo Porte de Versailles to participate in a programme of over 500 different sessions across the full spectrum of cardiovascular medicine. As ever, a large amount of the data and discussion focused on prevention of stroke in patients with atrial fibrillation (AF), reflecting the huge burden of this disease around the world.

Ver todo
Alt tag

Latest Video

Aspirina, EINSTEIN
CHOICE y tratamiento
de TEV a largo plazo

YYMMDD Author/Uploaded by

El profesor Paolo Prandoni analiza el papel del AAS en el tratamiento prolongado del TEV y analiza el reciente estudio EINSTEIN CHOICE, que comparó dos dosis de rivaroxabán con AAS para el tratamiento prolongado del TEV

N.º de autorización PP-XAR-ALL-1747-1

Únase a la conversación

Thrombosis Connection es un foro de profesionales
sanitarios destinado a compartir, crear y fomentar
soluciones innovadoras en el campo de la trombosis.

Join more than 1.500 of your peers to stay up to date with the latest in thrombosis.

Sign up now!